MBM Wealth Consultants’s AtriCure ATRC Stock Holding History

MBM Wealth Consultants’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73	Closed	-$3K	–	279
2022 Q4	$3K	Buy	+73	New	+$3.05K	﹤0.01%	282

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MBM Wealth Consultants's ATRC Position: Q1 2023 in Review

MBM Wealth Consultants sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 73 shares — an estimated $3K sold.

MBM Wealth Consultants first reported a position in ATRC in Q4 2022 and held it in 1 quarter. The position peaked at $3K in Q4 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

MBM Wealth Consultants reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
MBM Wealth Consultants sold 73 AtriCure shares in Q1 2023, an estimated $3K.
MBM Wealth Consultants first reported a position in AtriCure in Q4 2022 and held it in 1 quarter.
MBM Wealth Consultants's AtriCure position peaked at $3K in Q4 2022.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on MBM Wealth Consultants's 13F filing for Q1 2023, filed 31 May 2023.